Details of the Drug

General Information of Drug (ID: DM7KBD0)

Drug Name

AZD6234

Indication

Disease Entry	ICD 11	Status	REF
Obesity	5B81	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Peptide

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05511025) A Phase I Randomized Single-blind Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese. U.S.National Institutes of Health.